Skip to content
HomeArchives for pixelentropyPage 2

pixelentropy

Pancreatic Cancer Europe

ESMO GI 2017

Pancreatic Cancer Europe is proud to endorse ESMO World Congress on Gastrointestinal Cancer 2017. The ESMO World Congress on Gastrointestinal Cancer is the premier global event in the field – encompassing malignancies affecting…   …Read More »ESMO GI 2017

Pancreatic Cancer Europe

Pancreatic cancer will this year become the third biggest cancer killer in the EU

At the occasion of the 49th meeting of the European Pancreatic Club (EPC), the founding members of Pancreatic Cancer Europe*, newly established as a non-profit association, gathered in Liverpool on 6 July. This meeting marked a new milestone in the life of Pancreatic Cancer Europe, and its continued work to improve the prioritisation of pancreatic  ...Read More »Pancreatic cancer will this year become the third biggest cancer killer in the EU
Pancreatic Cancer Europe

Two-drug combination improves survival for operable pancreatic cancer

The results of a large pan-European study by the European Study Group for Pancreatic Cancer (ESPAC) involving 732 patients has shown that the combination of gemcitabine plus capecitabine adjuvant therapy (following successful resection of the tumour) significantly improved survival. Presented at the American Society for Clinical Oncology1 in Chicago this week, the lead researchers from  ...Read More »Two-drug combination improves survival for operable pancreatic cancer
Pancreatic Cancer Europe

Have we now found a way for immunotherapy to work in pancreatic cancer too?

We have seen a lot in the press recently about the advances in immunotherapy for many cancers and, in the case of melanoma, with extraordinary results. We’ve not as yet seen this happen for pancreatic cancer which, so far, has proven difficult to treat with either conventional chemotherapy and/or novel immunotherapy. Some trials of immunotherapy  ...Read More »Have we now found a way for immunotherapy to work in pancreatic cancer too?
Pancreatic Cancer Europe

Launch of the Pancreatic Cancer Overall Survival Registry EUROPE (PancreOS)

Pancreatic cancer will become the 2nd leading cause of cancer-related death by the year 2030. There are different standards, therapies and settings in the European countries. Furthermore, there is no target-oriented treatment for patients with pancreatic cancer. “We treat all patients with Pancreatic cancer alike”, Professor Alfredo Carrato said, “but there are different groups and  ...Read More »Launch of the Pancreatic Cancer Overall Survival Registry EUROPE (PancreOS)
Pancreatic Cancer Europe

World Pancreatic Cancer Day 2015

On the occasion of the 2nd World Pancreatic Cancer Day, the European Multi-Stakeholder Platform on Pancreatic Cancer held its third face-to-face meeting in the European Parliament, in Brussels, on November 10th.